Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.32%
1,100.57
-3.53
-0.32%
—1,104.101,103.921,108.751,097.16——
SIXC
Communications
SIXC
Communications
SIXC
+0.16%
605.15
+0.99
+0.16%
—604.16604.16610.19604.12——
SIXE
Energy
SIXE
Energy
SIXE
-0.22%
1,195.19
-2.62
-0.22%
—1,197.811,200.581,213.071,192.02——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.03%
1,739.91
-0.50
-0.03%
—1,740.411,739.551,750.271,730.60——
SIXM
Financials
SIXM
Financials
SIXM
+0.65%
638.56
+4.12
+0.65%
—634.44633.13639.87633.01——
SIXR
Staples
SIXR
Staples
SIXR
-1.11%
831.57
-9.33
-1.11%
—840.90839.53841.73831.10——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.82%
213.36
-1.77
-0.82%
—215.13215.13215.85213.24——
SIXT
Technology
SIXT
Technology
SIXT
+0.17%
3,234.18
+5.47
+0.17%
—3,228.713,225.623,235.433,198.95——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.02%
935.65
-0.22
-0.02%
—935.87938.37942.00935.65——
SIXV
Health care
SIXV
Health care
SIXV
-0.54%
1,449.26
-7.86
-0.54%
—1,457.121,452.741,466.881,449.18——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,382.45
-17.39
-0.72%
—2,399.842,389.712,394.612,371.22——
BOT:ASX
Botanix Pharmaceuticals Ltd
A$0.030
-6.25%
(-0.0020) 1D
Apr 28, 4:14:15 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for BOT...
Open
A$0.03
High
A$0.03
Low
A$0.03
Mkt. cap
87.02M
Avg. vol.
27.12M
Volume
47.77M
52-wk high
A$0.48
52-wk low
A$0.03
EPS
-A$0.05
Shares outstanding
2.72B
No. of employees
11
News stories
From sources across the web
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
CEO-
Employees11
Founded1984
Headquarters-
SectorPharmaceutical industry
Websitebotanixpharma.com
Last report
Jan 26, 2026
Fiscal Period
Q2 2026
Normalized EPS / Estimate
-/ -AUD
Revenue / Estimate
8.25M/ (- est.)AUD
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
2.71M
2.71M
8.25M
8.25M
Cost of goods sold
1.28M
1.28M
2.98M
2.98M
Cost of revenue
1.28M
1.28M
2.98M
2.98M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
21.36M
21.36M
18.32M
18.32M
Operating expense
26.90M
26.90M
22.08M
22.08M
Total operating expenses
28.18M
28.18M
25.06M
25.06M
Operating income
-25.47M
-25.47M
-16.81M
-16.81M
Other non operating income
-
-
683.30K
683.30K
EBT including unusual items
-27.75M
-27.75M
-16.60M
-16.60M
EBT excluding unusual items
-27.75M
-27.75M
-16.60M
-16.60M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-27.75M
-27.75M
-16.60M
-16.60M
Net profit margin
-1,025.73%
-1,025.73%
-201.11%
-201.11%
Earnings per share
-
-
-
-
Interest and investment income
347.27K
347.27K
352.66K
352.66K
Interest expense
-2.67M
-2.67M
-802.39K
-802.39K
Net interest expenses
-2.32M
-2.32M
-449.74K
-449.74K
Depreciation and amortization charges
572.87K
572.87K
593.18K
593.18K
EBITDA
-24.90M
-24.90M
-16.22M
-16.22M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer